About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Baltimore | 454 Studies

Clinical Trials Prostate CancerBaltimore

Prostate Cancer Clinical Trials in Baltimore

Find 454 clinical trials for prostate cancer near Baltimore, Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 454 trials

CompletedA Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate CancerThis is the first study of MLN2704 administered to humans.NCT00052000·Baltimore, Maryland and 1 other RecruitingA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalutamide in…NCT06136650·Tucson, Arizona and 329 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPost-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic SurgeryORIOLES is a non-randomized, pre-post intervention study designed to improve quality of opioid prescribing and use after discharge for patients undergoing urologic surgery.NCT03536065·Baltimore, Maryland

CompletedA Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerThis is a Phase 3 randomized, double blind, placebo controlled study of tasquinimod in asymptomatic to mildly symptomatic patients with metastatic CRPC to confirm the effect of…NCT01234311·Tucson, Arizona and 203 others

CompletedAbiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyThis is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant…NCT00638690·Birmingham, Alabama and 126 others

CompletedRadiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002597·Birmingham, Alabama and 238 others

UnknownClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate BiopsyThe purpose of the study is to collect information on prostrate biopsy tissue for use in developing a method determining the difference in normal and cancerous prostrate tissue…NCT02928640·Denver, Colorado and 4 others

CompletedRadiation and Androgen Ablation for Prostate CancerA study to see how effective and tolerable radiation therapy along with androgen deprivation therapy is in treating prostate cancer.NCT01517451·Washington D.C., District of Columbia and 2 others

Active not recruitingA Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant…NCT06764485·Birmingham, Alabama and 211 others

CompletedStudy of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)The purpose of this study is to evaluate the efficacy and safety of olaparib versus enzalutamide or abiraterone acetate in subjects with metastatic castration-resistant prostate…NCT02987543·Anchorage, Alaska and 203 others

Active not recruitingTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialThis phase III trial uses the Decipher risk score to guide therapy selection.NCT05050084·Birmingham, Alabama and 575 others

WithdrawnViberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-ProstatectomyThe purpose of this study is to evaluate whether using penile vibratory stimulation with the Viberect handheld device can help the recovery of erections and urinary control after…NCT01718704·Baltimore, Maryland and 1 other

CompletedZoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone TherapyRATIONALE: Zoledronate may prevent bone loss in patients with prostate cancer undergoing radiation therapy and hormone therapy.NCT00329797·Chico, California and 87 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC).NCT06925737·Phoenix, Arizona and 297 others

CompletedRAdium-223 and SABR Versus SABR for Oligometastatic Prostate CancersThis is a Phase II non-blinded randomized study evaluating men with oligometastatic prostate cancer lesions randomized (1:1) to stereotactic ablative radiation therapy (SABR)…NCT04037358·Baltimore, Maryland

CompletedAndrogen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen ablation therapy may stop the adrenal glands from making androgens.NCT00309985·Anchorage, Alaska and 342 others

CompletedGenetic Analysis of Hereditary Prostate CancerMolecular approaches to the understanding of human neoplastic disease have revealed that multiple genetic alterations are an essential component of tumorigenesis.NCT00001469·Phoenix, Arizona and 7 others

CompletedProspective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYThis study will develop a first-in-man CTC-based molecular taxonomy of CRPC in the context of novel AR-directed therapies, categorize different patterns of resistance in this…NCT02269982·Chicago, Illinois and 4 others

TerminatedTestosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate CancerThe purpose of this study is to determine whether prostate cancer growth can be slowed in patients who receive Androgel® 1% at 10 gram dose.NCT00515112·Los Angeles, California and 10 others

TerminatedSaracatinib in Treating Patients With Prostate CancerThis randomized phase II clinical trial is studying how well saracatinib works in treating patients with prostate cancer.NCT01267266·Chicago, Illinois and 14 others

PreviousPage 11 of 23Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma